Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations 
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves 
Korea Ginseng Corporation inaugurated its research and development (R&D) center in California. The leading South Korean ginseng producer said on Wednesday, March 15, that it has set up a facility in the United States to expand its presence in the American market while also boosting its sales overseas.
Korea Ginseng Corp. is the maker of the no. 1 ginseng brand in the world known as CheongKwanJang. The opening of its R&D center in the U.S. is a major step toward increasing its market share in the region. Moreover, the center was built so the company can continue developing Korean ginseng into a product that will suit the preference of Americans.
As per The Korea Herald, the ginseng products manufacturer said that with its new R&D center, it would conduct research to find ways of enhancing and broadening the use of its flagship red ginseng products currently being sold in the U.S.
The company especially wants to bolster its products' capability of improving customers' immunity and memory and reducing fatigue. Aside from product development, the center will also serve as a hub that will manage the manufacturing process and quality control of the health products that will be made there.
Korea Ginseng Corp. mentioned its R&D in California will further function as an office for its business ventures in neighboring foreign markets, including Central and South America. The facility will collect data about health drinks and food markets so the company can improve its products based on the information.
"Our US R&D Center will contribute to the construction of local production infrastructure while strengthening the development of customized ginseng products for local consumers," KGC's chief executive officer, Heo Chul Ho, said during the R&D center's inauguration. "The U.S. R&D center will contribute to building infrastructure for a localized manufacturing line as well as strengthening development for localized products."
In a separate press release, the CEO of KGC US, Heung Sil Lee, further said, "This will be a momentous year for our global business. As we meet the unique needs of our U.S. customers by actively developing products specifically tailored to their lifestyles."
